Conversation with Welldoc

In this episode, Anand Iyer, Chief Strategy Officer of Welldoc, discusses the development and outcomes of Welldoc's BlueStar, a mobile prescription therapy for type 2 diabetes. They explore the potential for reversing diabetes, improving diabetes care through technology and data analysis, and the challenges of commercializing digital therapeutics. They also touch on the opportunities for improving healthcare through digital tools and data insights.